Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.0282352941176471 0.0505882352941176 0.0505882352941176
Stock impact report

Menlo Therapeutics Announces Senior Clinical Leadership Updates

MENLO THERAPEUTICS INC COMMON (MNLO) 
Last menlo therapeutics inc common earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.menlotherapeutics.com/investor-relations
Company Research Source: GlobeNewswire
REDWOOD CITY, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough, today announced a realignment of roles including the promotion of a key member of the clinical development team.  Paul Kwon, M.D., a board-certified dermatologist and Menlo’s Chief Medical Officer for the last two years, will become Menlo’s Chief Scientific Officer.  Dr. Kwon will be responsible for leading the scientific strategy of the serlopitant clinical program, exploring potential new indications and overseeing early-stage clinical trials of serlopitant to support the anticipated new drug application.  Mary Spellman, M.D., a board-certified dermatologist who has served as Menlo’s Senior Vice President, Clinical Development for the last year, will be promoted to Chief Medical Officer Show less Read more
Impact Snapshot
Event Time:
MNLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MNLO alerts
Opt-in for
MNLO alerts

from News Quantified
Opt-in for
MNLO alerts

from News Quantified